Viz.ai news and updates

Every material change AI Health Index has tracked at Viz.ai: new modules, model and architecture updates, clinical evidence, regulatory status, security certifications, and integration depth. Each entry states what changed, cites its source, and carries our read on what it means for a buyer. The graded assessment of this vendor across all fifteen capability axes sits on its index profile.

Funding rounds, valuations, and awards are not product changes and are not logged here. Acquisitions appear only where there is direct product impact.

Follow this change log by RSS

Free for your reader, newsletter or automation tool. One feed covers the whole index, and every category has its own.

All feeds and terms
Impact
Type
1 entry
Showing changes for Viz.ai only.Show the full log

November 2026

V
Viz.ai
Nov 6, 2026
LowPartially Verified
Clinical evidence

Viz.ai announced two abstracts on Viz HCM, the AI-ECG algorithm in the Viz Cardio Suite, accepted for the HCMS meeting held with AHA Scientific Sessions 2026. A University of Colorado study of ECGs from more than 29,000 patients found nearly 40 percent of patients flagged for suspected HCM had no matching diagnosis code, and a Beth Israel Deaconess study found flagged patients had a 2.68 fold higher hazard of adverse clinical events.

Our read

Adds real world evidence from two academic centers that the HCM algorithm finds patients missed by diagnosis code searches and standard ECG reads, which bears on the case finding yield a health system can expect. Both studies were funded by Bristol Myers Squibb through Viz.ai, so buyers should weigh them as sponsored abstracts, not peer reviewed papers.

Related axis: Clinical and Operational EvidenceVendor announcementView source

What has changed at Viz.ai recently?

The most recent change AI Health Index logged at Viz.ai is dated Nov 6, 2026. Viz.ai announced two abstracts on Viz HCM, the AI-ECG algorithm in the Viz Cardio Suite, accepted for the HCMS meeting held with AHA Scientific Sessions 2026.